Merck v. Gnosis

Summary Judgment Reply - When Defendant's Advertising is More Aligned with the International Standard than Plaintiff's, that is not False Advertising!

more+
less-

This is a Response to a sur reply in a Lanham Act false advertising case in SDNY. Plaintiff, Merck Eprova, claimed that my client, Gnosis, S.p.A., caused an independent GRAS panel of experts to change the nomenclature in their report to better its position in the litigation. Merck claimed that the independent panel started off using Merck's nomenclature but changed it to be more closely aligned with Gnosis' litigation position regarding nomenclature. A couple of major problems:

-First, the independent panel admitted that the nomenclature was confusing. Merck's burden in the case is to prove that the nomenclature is unambiguous.

-Second, the original nomenclature was not consistently Merck's; it was all over the board, showing confusion not clarity.

-Third, the nomenclature did not go from Merck's to Gnosis; it went from a mixture to the internationally recognized International Union of Pure and Applied Chemistry ("IUPAC") nomenclature.

-Fourth - and most importantly - Merck is now accusing Gnosis of changing the nomenclature from Merck's to the IUPAC's, which Merck admits is "more closely aligned" with the nomenclature Gnosis used and Merck claims is literally false.

Question: How can the nomenclature be "more closely aligned" with the worldwide standard and be "literally" false?

LOADING PDF: If there are any problems, click here to download the file.

Published In: Business Torts Updates, Civil Procedure Updates, Communications & Media Updates, Science, Computers & Technology Updates

Reference Info:Legal Memoranda: Motions for Summary Judgment/Adjudication | Federal, 2nd Circuit, New York | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© William Chapman, Julander, Brown, Bollard & Chapman | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

CONNECT

William Chapman
Julander, Brown, Bollard & Chapman

I believe my primary duty as an advocate for my clients is to search for the truth and shape my... View Profile »


Follow Julander, Brown, Bollard & Chapman:

Reporters on Deadline